TKT and neoplasm: Although HSV-tk expressing cells have demonstrated high anti-tumor efficacy and can be effectively killed, this approach has limitations such as the need for activation by a prodrug (ganciclovir) and a time of 3 days to achieve full effect in vitro (144).